FDA policy proposal affects the operations of AI, Inc.

The entities involved

• FDA →
  • Krsnaa Diagnostics leverages AI technology from AZmed, which secured FDA 510(k) clearances, to provide diagnostics across 19 Indian states.07:23
  • The FDA has posted a nationwide recall notice.07:10
• AI, Inc. →
  • AI, Inc. regained compliance with Nasdaq listing rules on October 20, 2026, with the announcement originating from Tampa.Tue 12:01

Related events

• PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.Sep 5
• Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.Aug 27
• Arise is seeking FDA approval for a drug as of October 7, 2026.Oct 7
• FDA approval enables commercial availability for a product associated with Indianapolis.Oct 6
• Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.Thu 12:55